| Literature DB >> 23977057 |
Shih-Wei Lin1, Yen-Lung Chen, Kuo-Chin Kao, Cheng-Ta Yang, Li-Pang Chuang, Yu-Ting Chou, Szu-Chia Lai, Rou-Shayn Chen, Ning-Hung Chen.
Abstract
STUDYEntities:
Mesh:
Year: 2013 PMID: 23977057 PMCID: PMC3747238 DOI: 10.1371/journal.pone.0071499
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographics of patients who fulfilled all the criteria for restless leg syndrome.
| Primary RLS | Other diseases | Total |
| |
| ( | ( | (n = 121) (%) | ||
|
| 0.021 | |||
| Male | 5 (27.8) | 59 (57.3) | 64 (52.9) | |
| Female | 13 (72.2) | 44 (42.7) | 57 (47.1) | |
|
| 0.539 | |||
| 21 to 30 | 3 (16.7) | 7 (6.8) | 10 (8.3) | |
| 31 to 40 | 2 (11.1) | 22 (21.4) | 24 (19.8) | |
| 41 to 50 | 5 (27.87) | 29 (28.2) | 34 (28.1) | |
| 51 to 60 | 6 (33.3) | 26 (25.2) | 32 (26.4) | |
| 61 to 70 | 2 (11.1) | 13 (12.6) | 15 (12.4) | |
| Above 70 | 0 (0.0) | 6 (5.8) | 6 (5.0) | |
|
| ||||
| Insomnia+ | 12 (66.7) | 46 (44.7) | 58 (47.9) | 0.047 |
| Snoring or witnessed apnea | 2 (11.1) | 34 (33.0) | 36 (29.8) | 0.039 |
| Discomfort on limbs | 2 (11.1) | 16 (15.5) | 18 (14.9) | 0.269 |
| Daytime sleepiness | 1 (5.6) | 3 (2.9) | 4 (3.3) | 0.375 |
| Chest pain or tightness | 1 (5.6) | 3 (2.9) | 4 (3.3) | 0.375 |
| Low back pain | 0 (0.0) | 1 (1.0) | 1 (0.8) | - |
+Insomnia including dreamy sleep, difficulty in initiating or maintaining sleeping and poor sleep quality.
statistical significance between groups.
Diseases that Fulfilled the Criteria for RLS in Chang Gung Sleep Center.
|
| |
| Iron deficiency | 15 (12.4%) |
| With anemia | 5 (4.1%) |
| Without anemia | 10 (8.3%) |
| Thyroid dysfunction | 4 (3.3%) |
| Hyperthyroidism | 2 (1.7%) |
| Hypothyroidism | 2 (1.7%) |
| Obstructive sleep apnea | 67 (55.4%) |
| Neuropathy | 35 (28.9%) |
| Peripheral neuropathy | 17 (14.0%) |
| Polyneuropathy | 8 (6.6%) |
| Radiculopathy | 3 (2.5%) |
| Myelopathy | 7 (5.8%) |
| End-stage renal disease | 9 (7.4%) |
| Parkinson's disease | 5 (4.1%) |
| Rheumatic disease | 2 (1.7%) |
| Medication-related (antidepressants) | 2 (1.7%) |